The provocative findings by Pich et al. (Apr. 24 issue)1 showing the influence of tumor-infiltrating clonal hematopoiesis (TI-CH) on patient outcomes in early-stage cancers support the… […]
Regorafenib response prediction in metastatic colorectal cancer by a novel genomic and transcriptomic model
Introduction: Regorafenib is a third-line option in metastatic CRC, often overshadowed by its limited efficacy and high toxicity. Yet, rare cases of deep and even… […]
